Bovie Medical Seeks FDA Approval for Surgical Device

Bovie Medical Corp. has applied for pre-market clearance from the Food and Drug Administration for a device designed for use in orthopedic surgeries.

The device, named BOSS, primarily will be targeted toward orthopedic hip and knee reconstruction surgeries, Bovie said in a release. There are more than 1.3 million such procedures performed in the United States annually, and the market is growing due to a move active and aging population. The worldwide market is expected to exceed $500 million this year, the release said.

BOSS is the latest generation device based on Bovie’s use of conductive sintered steel as an electrode for radio frequency cutting and coagulation. It is intended to lower blood loss, quicken procedure times and provide cost savings, Bovie said in a filing with the Securities and Exchange Commission.